CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Birmingham, Alabama, United States and 144 other locations
Performance of the LumiraDx SARS-CoV-2 Ag ULTRA assay will be assessed by comparison to a reference method
Birmingham, Alabama, United States and 6 other locations
The Metrix COVID Test will be evaluated for use in Point-of-Care and Non-Laboratory settings in a home testing environment utilizing the clinical stu...
Birmingham, Alabama, United States and 2 other locations
This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19...
Phase 4
Birmingham, Alabama, United States and 98 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
Cullman, Alabama, United States of America and 221 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 3
Birmingham, Alabama, United States and 100 other locations
the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...
Phase 4
Birmingham, Alabama, United States and 149 other locations
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health proble-...
Phase 3
Birmingham, Alabama, United States and 199 other locations
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...
Phase 2, Phase 3
Birmingham, Alabama, United States and 90 other locations
The purpose of this study is to compare two approaches to cognitive rehabilitation in adults with post-viral cognitive syndrome, which resulted in br...
Birmingham, Alabama, United States
Clinical trials
Research sites
Resources
Legal